Gross Profit: Revenues from operations less the associated costs.
Calithera Biosciences, Inc. (CALA) Gross Profit data is not available for the most recently reported fiscal quarter, ending 2022-12-31.
| Income Statement Financials | |
-- |
|
$-5.57M |
|
-- |
|
|
Gross Profit |
-- |
$7.35M |
|
$-7.35M |
|
$0.41M |
|
$-6.94M |
|
$-6.94M |
|
$-6.94M |
|
$-6.94M |
|
$-6.94M |
|
$-6.94M |
|
$-7.35M |
|
$-7.28M |
|
4.63M |
|
4.99M |
|
$-0.62 |
|
$-3.72 |
|
| Balance Sheet Financials | |
$26.62M |
|
$0.43M |
|
$2.05M |
|
$28.68M |
|
$7.39M |
|
-- |
|
$0.89M |
|
$8.28M |
|
$-1.95M |
|
$20.39M |
|
$20.39M |
|
4.87M |
|
| Cash Flow Statement Financials | |
$-43.61M |
|
$-0.13M |
|
$9.65M |
|
$59.81M |
|
$25.72M |
|
$-34.09M |
|
$4.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-43.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
355.68% |
|
-34.01% |
|
-24.19% |
|
-34.01% |
|
$4.19 |
|
$-8.76 |
|
$-8.74 |
|